+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era



Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era



Current Hiv/Aids Reports 5(3): 140-149



In the highly active antiretroviral therapy (HAART) era, the incidence of AIDS-defining malignancies (ADMs) has declined significantly. On the other hand, the incidence of other malignancies not known to be associated with immunosuppression (non-ADMs) has not changed and remains significantly higher than in the general population. Some recent controlled studies even suggest that the incidence of selected non-ADMs has increased in the HAART era. These trends warrant a high index of suspicion for malignancies among HIV care providers and a renewed focus on understanding the mechanisms underlying the increased rates. Potential explanations for the higher non-ADM rates include longer survival of patients with HIV on HAART, with only partial immune recovery achieved in most patients; high incidence of human papillomavirus, Epstein-Barr virus, and hepatitis C virus coinfection in patients with HIV infection; and potential oncogenicity of long-term HIV infection or of long-term HAART.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054636128

Download citation: RISBibTeXText

PMID: 18627663

DOI: 10.1007/s11904-008-0022-4


Related references

AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethnicity and Disease 18(2 Suppl 2): S2, 2008

Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy. Aids 28(16): 2407-2415, 2014

Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy. Recenti Progressi in Medicina 100(12): 547-549, 2009

Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. Journal of Clinical Oncology 21(18): 3447-3453, 2003

Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy. Aids Reviews 14(1): 3-16, 2012

Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clinical Infectious Diseases 52(12): 1458-1465, 2011

Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era. Journal of Korean Medical Science 32(9): 1445-1450, 2017

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. American Journal of Epidemiology 165(10): 1143-1153, 2007

Potential Utility of Highly Active Antiretroviral Therapy in Patients with AIDS Related Malignancies Who Do Not Show Virological or Immunoligcal Response. Blood 100(11): Abstract No 1821, 2002

Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort. Clinical Microbiology and Infection 19(7): 646-653, 2013

AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16(4): 441-51 456 459, 2002

Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy. Diseases of the Colon and Rectum 47(9): 1483-1486, 2004

AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database. International Journal of Std and Aids 18(7): 446-452, 2007

Effects of the introduction of highly active antiretroviral therapy (HAART) on the temporal trend of diagnosis of AIDS and AIDS-defining disorders. Le Infezioni in Medicina 8(3): 134-138, 2000

Three to seven concurrent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy. Aids 16(17): 2356-2358, 2002